PBS Calendars

Page last updated: 12 March 2021

PBS related activities surrounding the PBAC meeting cycles

If you are considering applying to have a drug listed on the PBS, it is recommended that you contact the Office of Health Technology Assessment (OHTA) to discuss the listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison Officer will be able to assist.

All contact details are available from the PBS contacts page.

PBAC Cycle Timeframe for 2021 - 2022

PBAC Cycle Timeframe for 2021 - 2022 (PDF 206KB) - (Word 32KB)

PBAC CYCLE TIMEFRAME FOR 2021-2022

MEETING

2020/3
4-6 November

2021/1
10-12 March

2021/2
7-9 July

2021/3
3-5 November

2022/1
9-11 March

Activity

Wk

 

Wk

 

Wk

Date

Wk

Date

Wk

Date

Deadline for Intent to Apply for integrated co-dependent submissions (Wednesday 5pm AEST)

-8

N/A

-8

N/A

-8

13 Jan 2021

-8

12 May 2021

-8

8 Sep 2021

 

-7

 

-7

 

-7

 

-7

 

-7

 

 

-6

 

-6

 

-6

 

-6

 

-6

 

 

-5

 

-5

 

-5

 

-5

 

-5

 

Deadline for Intent to Apply for Category 1-4 and Committee Secretariat submissions; and Standard Re-entry resubmissions (Wednesday 5pm AEST)

 

 

Deadline for integrated co-dependent submissions (Wednesday 5pm AEST)

-4

N/A

 

 

N/A

-4

N/A

 

 

N/A

-4

10 Feb 2021

 

 

10 Feb 2021

-4

9 Jun 2021

 

 

9 Jun 2021

-4

6 Oct 2021

 

 


6 Oct 2021

 

-3

 

-3

 

-3

 

-3

 

-3

 

 

-2

 

-2

 

-2

 

-2

 

-2

 

 

-1

 

-1

 

-1

 

-1

 

-1

 

Deadline for Category 1 to 4 and Committee Secretariat submissions; and Facilitated Resolution Pathway and Standard Re-entry Pathway resubmissions (Wednesday 5pm AEST)

0

N/A

0

N/A

0

10 Mar 2021

0

7 Jul 2021

0

3 Nov 2021

 

1

 

1

 

1

 

1

 

1

 

 

2

 

2

 

2

 

2

 

2

 

Publication of the main Agenda on web (Wednesday)

 

Consumer Comments open (Wednesday)

3

N/A

 

 

N/A

3

N/A

 

 

N/A

3

31 March 2021
 

 

31 March 2021

3

28 July 2021

 

 

28 July 2021

3

24 Nov 2021

 

 

24 Nov 2021

 

4

 

4

 

4

 

4

 

4

 

 

5

 

5

 

5

 

5

 

5

 

Deadline for Intent to Apply for Early Resolution and Early Re-entry Pathway resubmissions (Friday 5pm AEST)

6

N/A

6

N/A

6

23 April 2021

6

20 Aug 2021

6

17 Dec 2021

Deadline for Early Resolution and Early Re-entry Pathway resubmissions (Friday 5pm AEST)

7

N/A
 

7

N/A

7

30 April 2021

7

27 Aug 2021

7

23 Dec 2021
(24 Dec – 2 Jan Dept shutdown)

Publication of the updated Agenda on web (Friday)

8

N/A

8

N/A

8

7 May 2021

8

3 Sept 2021

8

5 Jan 2022
(24 Dec – 2 Jan Dept shutdown)

Pre-submission meetings: 8 week cut-off

9

N/A

9

11-15 Jan 2021

9

10-14 May 2021

9

6-10 Sept 2021

9

10-14 Jan 2022

Submission commentaries to Applicants (Wednesday)

 

10

N/A

10

20 Jan 2021

10

19 May 2021

10

15 Sept 2021

10

19 Jan 2022

Applicants’ Pre Subcommittee Responses (PSCRs) to PBAC Secretariat (midday Wednesday)

 

Consumer comments close (Wednesday)

11

N/A
 

 

 

N/A

11

27 Jan 2021

 

 

*Please see week 13*

11

26 May 2021

 

 

26 May 2021

11

22 Sept 2021

 

 

22 Sept 2021

11

27 Jan 2022

(PH 26 Jan)

 

 

27 Jan 2022

(PH 26 Jan)

 

 


19 Jan 2022

DUSC meeting (Thursday-Friday)

 

12

N/A

12

4-5 Feb 2021

 

12

3-4 June 2021

 

12

30 Sept – 1 Oct 2021

12

3-4 Feb 2022

 

ESC meeting (Monday-Tuesday)

 

 

Consumer Comment close (Wednesday)
March 2021 round only

13

N/A

13

8-9 Feb 2021
 

 

10 Feb 2021

13

7-8 June 2021


*Please see week 11*

 

13

5-6 Oct 2021

(PH 4 Oct)

*Please see week 11*

13

7-8 Feb 2022

 

*Please see week 11*

 

14

 

14

 

14

 

14

 

14

 

Submission overviews, ESC, DUSC & ATAGI (vaccine submissions) advice & summary of consumer comments to Applicants (Wednesday)

15

N/A

15

24 Feb 2021
 

15

23 June 2021

15

20 Oct 2021

15

24 Feb 2022

Applicants send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday)

16

N/A

16

3 Mar 2021

16

30 June 2021

16

27 Oct 2021

16

2 Mar 2022

PBAC meeting Wednesday-Friday
 

17

N/A

17

10-12 Mar 2021

17

7-9 July 2021

17

3-5 Nov 2021

17

29-11 Mar 2022

POST PBAC PROCEDURES:

18

 

18

 

18

 

18

 

18

 

 

19

 

19

 

19

 

19

 

19

 

Ratified Minutes (positive outcomes) to Applicants (Friday)

20

N/A

20

1 Apr 2021
(PH 2 Apr)

20

30 July 2021

20

26 Nov 2021

20

1 Apr 2022

 

21

 

21

 

21

 

21

 

21

 

Ratified Minutes (all other outcomes) to Applicants (Friday)

22

N/A

22

16 Apr 2021

22

13 Aug 2021

22

10 Dec 2021

22

14 Apr 2022

(PH 15 Apr)

Post-PBAC meetings with PBAC Chair (Tue-Wed)

 

 

Posting of outcomes on website following Applicants’ comments (Friday)

23

15-16 Dec 2020

 

 

18 Dec 2020

23

20-21 Apr 2021

 

 

23 Apr 2021

 

23

16-17 Aug 2021

 

 

20 Aug 2021

 

23

14-15 Dec 2021

 


17 Dec 2021

 

23

19-20 Apr 2022

 

 

22 Apr 2022

Deadline for Independent Review requests for reconsideration at the meeting following the next meeting (Friday)

24

24 Dec 2020

24

30 Apr 2021

24

27 Aug 2021

24

24 Dec 2021

24

29 April 2022

 

25

 

25

 

25

 

25

 

25

 

 

26

 

26

 

26

 

26

 

26

 

Draft Public Summary Documents (PSDs) to Applicants (Friday)

27

22 Jan 2021

27

21 May 2021

27

17 Sept 2021

27

21 Jan 2022

27

20 May 2022

 

28

 

28

 

28

 

28

 

28

 

 

29

 

29

 

29

 

29

 

29

 

 

30

 

30

 

30

 

30

 

30

 

Finalisation of PSDs (Friday)

31

19 Feb 2021

31

18 June 2021

31

15 Oct 2021

31

18 Feb 2022

31

17 Jun 2022

 

32

 

32

 

32

 

32

 

32

 

PSDs published on website (positive & subsequent rejections) (Friday)

33

5 Mar 2021

33

2 July 2021

33

29 Oct 2021

33

4 Mar 2022

33

1 July 2022

 

34

 

34

 

34

 

34

 

34

 

PSDs published on website (1st time rejections & deferrals) (Friday)

35

19 Mar 2021

35

16 July 2021

35

12 Nov 2021

35

18 Mar 2022

35

15 July 2022

 

PBAC = Pharmaceutical Benefits Advisory Committee

“responsible persons” = legal wording requirement for terminology – previously known as sponsors
DUSC = Drug Utilisation Sub Committee    
ESC = Economic Sub Committee
ATAGI = Australian Technical Advisory Group on Immunisation
PSDs = Public Summary Documents
TBC = To be Confirmed
    
*  These dates may vary based on the number of submissions received    

Accessibility

The documents on this page may not be accessible. If you need help please contact HTA compliance (secretariat.compliance@health.gov.au).

Pre-submission meetings

Sponsors may apply for a pre-submission meeting with the Department at any time. Pre-submission meetings are held throughout the entire PBAC meeting cycle, subject to availability. Please refer to the PBS Calendar above in relation to cut-off dates for applications submitting to the next major submission deadline. Additional information on procedures and links to application and briefing paper templates are outlined in the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.

If the item to be discussed is a co-dependent technology, sponsors should separately contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to discuss the required MSAC processes.

Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology.  For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.

If you have any questions regarding pre-submission meetings, please contact the Pre-submission Meetings Team via email (PBACpresubmissionmeetings@health.gov.au).